Abstract. Immunodominant antigens of an approximate molecular mass of 27 kD were obtained from an excretory-secretory product of adult Fasciola gigantica by a continuous-elution method. An indirect ELISA using the antigens obtained by this relatively simple procedure was developed for detecting specific antibodies from patients infected with F. gigantica. Sera from patients with other parasitic infections, healthy volunteers, and cholangiocarcinoma were also analyzed. The sensitivity, specificity, and positive and negative predictive values for this ELISA using the fractionated antigens were 100%. The data indicated a possible correlation of antibodies to F. gigantica with cholangiocarcinoma.
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Fascioliasis is a disease caused by hermaphroditic trematodes of the genus, Fasciola, of which F. hepatica and F. gigantica are the most common representatives. 1 The disease is recognized as an important condition by the World Health Organization and recent reports estimate that 2.4 million people are presently infected. In many areas of the tropics and subtropics, the disease causes a serious public health problem. [1] [2] [3] [4] Humans are usually infected by the ingestion of aquatic plants that contain the infective metacercariae.
The parasitologic diagnosis of human fascioliasis is often unreliable because the parasite eggs are not found during the prepatent period. Even when the worms have matured, the diagnosis may still be difficult since eggs are only intermittently released. Repeated examinations of stools are usually required to increase the accuracy of the diagnosis. Early diagnosis of fascioliasis is necessary for the institution of prompt treatment before irreparable damage to the liver occurs. For these reasons, serology is the most dependable diagnostic method. Attempts have been made to diagnose human fascioliasis by detecting antibodies in the serum of patients suspected of being infected with the flukes. Numerous immunodiagnostic tests have been used with an emphasis on F. hepatica infection. [5] [6] [7] [8] Specific antigens in the somatic extract and excretory-secretory (ES) product of F. gigantica adults were identified and characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting analysis. [9] [10] [11] One antigenic component from the adult ES product with an approximate molecular mass of 27 kD was found to give a consistent reaction with human fascioliasis sera (100% sensitivity and 98% specificity). 11 The purpose of the present study was to isolate the 27-kD antigen from the crude ES products using a newly developed continuous elution method for the diagnosis of human fascioliasis.
MATERIALS AND METHODS
Human sera. Sera from humans were obtained from serum banks kept in different sections of the Faculty of Medicine, Khon Kaen University. The collections were started several years before the present investigation began. The study protocol was approved by the Scientific-Ethical Committee of the Khon Kaen University. Informed consent was obtained from the study subjects using a standard approved procedure.
Twelve fascioliasis sera were obtained from parasitologically confirmed cases of infection with F. gigantica. Each of these was selected on the basis of the removing F. gigantica adult worms during cholecystectomy and T-tube choledochostomy or other bile duct operations. To assess potential cross-reactivity, 126 serum samples obtained from individuals with parasitic diseases other than fascioliasis were used. These samples were obtained from parasitologically confirmed cases of gnathostomiasis, angiostrongyliasis, paragonimiasis, opisthorchiasis, cysticercosis, trichinosis, malaria, and hookworm infection. Other parasitosis sera were obtained from cases who were positive for parasites or their products. Twenty-seven sera were obtained from patients whose pathologic features were compatible with a diagnosis of bile duct cancer or cholangiocarcinoma. Negative control sera were obtained from 46 healthy adults. Examination of their stools at the time of the blood collections were performed using the formalin-ether concentration method; 12 this gave no evidence of intestinal parasitic infections.
Preparation of crude ES antigen. Adult F. gigantica were obtained from the livers of infected cattle from an endemic area in Khon Kaen. The worms were washed with sterile saline and identified as F. gigantica according to criteria previously described. 13, 14 The ES antigen was prepared from a spent culture medium (RPMI 1640) containing 0.1 mM phenylmethylsulfonyl fluoride, 0.1 mM tosylamide-2-phenylethyl-chloromethyl ketone, 1 m of L-trans-3-carboxyoxiran-2-carbonyl-L-leucylagmatine, 100 units/ml of penicillin, and 100 g/ml of streptomycin in which the worms had been maintained for 6 hr at 37ЊC under 5% CO 2 in air. After incubation, the worms were removed and the collected spent medium was clarified by centrifugation at 10,000 ϫ g for 30 min at 4ЊC. The medium was concentrated by ultrafiltration using Amicon YM 3 membrane filter (Grace & CO., Danvers, MA), dialyzed against distilled water containing the same proteinase inhibitors, aliquoted, and stored at Ϫ40ЊC before being used.
Production of specific antigen by continuous-elution SDS-PAGE. The continuous-elution SDS-PAGE was performed using the Prep-Cell (Model 491; Bio-Rad, Hercules, CA) as recommended by the manufacturer. The discontinu- ous buffer system was used. A cylindrical column of polyacrylamide gel was prepared using a 28-mm internal diameter casting tube. It consisted of an upper 4% stacking gel and lower 12% gel with heights of 2 cm and 5.5 cm, respectively. The casting tube was assembled with the upper and lower buffer chambers and the latter was connected to an external recirculation pump (Bio-Rad). The crude ES sample containing 5 mg of protein was boiled for 5 min in 1 ml of sample buffer (10% glycerol, 5% 2-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl, pH 6.8, 0.001% bromphenol blue) before loading in the gel. The recirculation pump speed was operated at 100 ml/min. The sample was subjected to electrophoresis for 10 hr at 250 V, 40m A, and 12 W. Resolved proteins were collected at the base of the gel column using a dialysis membrane with a 6-kD cut-off. The purified proteins were continuously eluted at a flow rate of 1 ml/min using an external peristaltic pump (Econo-Pump; Bio-Rad). The absorbance of the eluant at 280 nm was monitored using a UV monitor (Model EM-1; Bio-Rad). The cut-off absorbance was an optical density (OD) of 0.05 and fractionated proteins were retrieved using a programmable fraction collector (Model 2128; Bio-Rad). Fractions of 2.5 ml provided sufficient separation. The fractions containing the specific component with an approximate molecular mass of 27 kD were identified by SDS-PAGE. These fractions containing the component of interest were pooled, dialyzed, and lyophilized.
Analytical SDS-PAGE. The eluants were analyzed by SDS-PAGE using the Mini-Protean II Cell (Bio-Rad), under reducing conditions on a 10-18% gradient gel prepared by the method of Laemmli. 15 After electrophoresis, the resolved polypeptides were revealed by staining with Coomassie brilliant blue.
Indirect ELISA. The solid phase ELISA was performed in microtiter plates as described previously. 16 Optimum conditions were determined by a checkerboard titration against pooled positive and negative reference sera. The optimum antigen concentration was 0.5 g/well. The enzyme conjugate used was peroxidase-conjugated goat anti-human IgG (Cappel Laboratories, Westchester, PA). Sera were tested at a 1:200 dilution. The positive and negative reference sera were included in each microtiter plate for correction of dayto-day variation. The absorbance at 490 nm of the plate was read using a microplate ELISA reader.
Other technique. The protein concentration was determined as described by Lowry and others 17 with bovine serum albumin used as the standard.
Data analysis. The statistical analysis was performed using Student's t-test and/or the Mann-Whitney rank sum test using Sigma Stat (San Rafael, CA) statistical software, as appropriate. Probabilities (P values) Ͻ 0.01 were considered significant. The diagnostic sensitivity, specificity, and predictive values were calculated using the method of Galen. 18 These values were calculated and expressed as follows: sensitivity ϭ [no of true positives/(no. of true positives ϩ no. of false negatives)] ϫ 100; specificity ϭ [no. of true negatives/(no. of false positives ϩ no. of true negatives)] ϫ 100; positive predictive value ϭ [no. of true positives/(no. of true positives ϩ no. of false positives)] x 100; negative predictive value ϭ [no. of true negatives/(no. of true negatives ϩ no. of false negatives)] ϫ 100; true negative ϭ number of control samples (other parasitosis and healthy controls) that were negative by ELISA; true positive ϭ number of proven fascioliasis samples that were positive by ELISA; false positive ϭ number of control samples that were positive by ELISA; false negative ϭ number of proven fascioliasis samples that were negative by ELISA.
RESULTS
The SDS-PAGE analysis and Coomassie brilliant blue staining of the crude and fractionated ES antigens of F. gigantica are shown in Figure 1 . The fractionated ES antigen containing the 27-kD component was used in an ELISA for the detection of IgG antibody in sera from patients with proven fascioliasis. The results were compared with those obtained using sera from patients with parasitic diseases other than fascioliasis, those with cholangiocarcinoma, and healthy controls (Figure 2 ). The mean, standard deviations, and ranges of optical densities (ODs) at 490 nm of sera of all 4 groups are shown in Table 1 . There was a significant difference in mean OD values between cases of proven fascioliasis (group 1) and cases of parasitic diseases other than fascioliasis (group 2), cholangiocarcinoma (group 3), and healthy controls (group 4) (P Ͻ 0.01), respectively. If the absorbance value of 0.55 (which was equivalent to the absorbance value of the mean plus 4 SD of the healthy control group) was used as the cut-off limit between positivity and negativity for fascioliasis, the sensitivity, specificity, and positive and negative predictive value were all 100%. However, 7 of 27 cholangiocarcinoma patients from the endemic area of fascioliasis gigantica showed a low ELISA reaction. FIGURE 2. Enzyme-linked immunosorbent assay using the fractionated excretory-secretory antigens in sera from cases with proven fascioliasis, parasitic diseases other than fascioliasis, cholangiocarcinoma, and healthy controls. Sera groups: 1 ϭ fascioliasis; 2 ϭ healthy controls: 3 ϭ paragonimiasis; 4 ϭ opisthorchiasis; 5 ϭ hookworm infection; 6 ϭ gnathostomiasis; 7 ϭ angiostrongyliasis; 8 ϭ cysticercosis; 9 ϭ trichinosis; 10 ϭ malaria; 11 ϭ cholangiocarcinoma; 12 ϭ other parasitosis as described in Table 1.   TABLE 1 Absorbance values of various sera in an indirect ELISA using the fractionated excretory-secretory antigen of Fasciola gigantica containing the 27-kD component 
DISCUSSION
Several groups have recently reported the purification of the immunodominant antigens from the ES products of the liver fluke for the immunodiagnosis of fascioliasis. 19, 20 Of these, only one described the use of a purified 27-kD cysteine proteinase from Japanese Fasciola spp. and its evaluation as an antigen in the diagnosis of human disease. 19 This proteinase demonstrated a high sensitivity and specificity in an ELISA for human fascioliasis, showing only 1 case of cross-reactivity with sera from schistosomiasis japonicum patients. Cordova and others 20 reported that the purified fractions Fas 1 and Fas 2, which contain a cysteine proteinase of F. hepatica with an approximate molecular mass of 25-26 kD, are specific and sensitive antigens for the diagnosis of this serious helminthic disease. In the present report, we used the partially purified fractions of the antigens with an approximate molecular mass of 27 kD from F. gigantica adult worms using a continuous elution SDS-PAGE. The assay is sensitive and specific and is valuable for the serodiagnosis of human fascioliasis. The procedure is simple and practical for use.
Low cross-reactivity with sera from patients with cholangiocarcinoma (25.9%) has been shown. However, this could be due to subclinical Fasciola spp. infection. In our study, we tested sera from patients with cholangiocarcinoma collected from northeast Thailand where people habitually consume raw or poorly cooked aquatic plants that harbor the infectious metacercariae of F. gigantica. The results suggest a possible association between cholangiocarcinoma and antibodies to F. gigantica similar to that with Opisthorchis viverrini infection. 21, 22 
